Caraco Pharmaceutical Laboratories Ltd.
1150 Elijah McCoy Drive
Detroit,
MI 48202
United States - Map
Phone: 313-871-8400
Fax: 313-871-8314
Web Site: http://www.caraco.com
| Caraco Pharmaceutical Laboratories, Ltd. engages in the development, manufacture, marketing, and distribution of generic, prescription, and over-the-counter pharmaceuticals for wholesalers, distributors, warehousing and non-warehousing chain drugstores, and managed care providers in the United States and Puerto Rico. It offers therapeutic drugs, such as analgesics, anorectics, antiallergics, antianxiety, antibiotics, anticonvulsants, antidepressants, antidiabetics, antiematics, anti-gouts, antihypertensive/beta blockers, antipsychotics, antithryoid agents, antitussive, anti ulcerants, bisphosphonate derivatives, calcium channel blockers, cardiac, decongestants, and narcotic analgesics. The companys therapeutic drugs also include nonsteroidal antiinflammatory agents, opiate agonist/analgesics, oncology adjuncts, Parkinsons disease, platelet aggregation inhibitors, sedatives and hypnotics, skeletal muscle relaxants, and vascular and migraine headache suppressants. It offers its products for central nervous system, cardiology, pain management, and diabetes. The company was founded in 1984 and is based in Detroit, Michigan. Caraco Pharmaceutical Laboratories, Ltd. is a subsidiary of Sun Pharmaceutical Industries Limited. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Jitendra N. Doshi , 57
Chief Exec. Officer |
N/A
| N/A | Mr. Mukul Rathi , 36
Interim Chief Financial Officer and Principal Accounting Officer |
$
111.00K |
$
0 | Mr. Robert Kurkiewicz , 58
Sr. VP of Regulatory |
$
167.00K |
$
0 | Mr. Gurpartap Singh Sachdeva , 40
Sr. VP of Bus. Strategies |
$
242.00K |
$
0 | Mr. Thomas Larkin ,
Director of Marketing |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.14% Nasdaq 0.00%
Profile
